Dr Desh Bandhu Gupta Net Worth

During the years, Lupin grew into one of the leading producers of anti-tuberculosis drugs and Cephalosporin antibiotics segments worldwide. Today, the company holds six research centers based in India and Japan, and it is operating in 12 factories with an income of about $1.7 billion annually. Last year, Gupta or, as he is popularly called, DBG handed over the pharmaceutical empire to his children: Vinita, his daughter, and Nilesh, his son, but he remains to serve as Chairman. Moreover, he was honored with the Lifetime Achievement Award for his contributions to the Pharmaceutical Leadership Summit in 2009, and he received the Visionary Leader award at 2011 Earnest and Young Entrepreneur of the Year Awards gala.